In This Article:
For the quarter ended December 2024, Quaker Chemical (KWR) reported revenue of $444.09 million, down 4.9% over the same period last year. EPS came in at $1.33, compared to $1.78 in the year-ago quarter.
The reported revenue represents a surprise of +0.54% over the Zacks Consensus Estimate of $441.71 million. With the consensus EPS estimate being $1.62, the EPS surprise was -17.90%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Quaker Chemical performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
-
Geographic Revenue- Americas: $208.59 million compared to the $201.35 million average estimate based on two analysts. The reported number represents a change of -7.9% year over year.
-
Geographic Revenue- Asia/Pacific: $109.62 million compared to the $106.70 million average estimate based on two analysts. The reported number represents a change of +4.6% year over year.
-
Geographic Revenue- EMEA: $125.88 million versus $130.05 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -7.3% change.
View all Key Company Metrics for Quaker Chemical here>>>
Shares of Quaker Chemical have returned +2.4% over the past month versus the Zacks S&P 500 composite's -0.5% change. The stock currently has a Zacks Rank #5 (Strong Sell), indicating that it could underperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Quaker Houghton (KWR) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).